Cellectis (CLLS) Gross Margin (2015 - 2023)
Cellectis (CLLS) posted quarterly Gross Margin of 103.94% for Q4 2023, up 10368.0% year-over-year from N/an in Q4 2022, and up 176.0% quarter-over-quarter from 136.77% in Q3 2023.
Powered by 
Analysis
Cellectis (CLLS) Gross Margin (2015 - 2023) Analysis & Trends
Cellectis' Gross Margin history runs 9 years deep, the most recent figure standing at 103.94% for Q4 2023.
- In Q4 2023, Gross Margin rose 10368.0% year-over-year to 103.94%; the TTM figure through Dec 2023 stood at 95.52% (up 9103.0% YoY), while the FY2025 annual figure was 100.0%, changed 0.0% from the prior year.
- Gross Margin for Q4 2023 stood at 103.94%, up from 136.77% in the prior quarter.
- The five-year high for Gross Margin was 103.94% in Q4 2023, with the low at 140.29% in Q1 2023.
- The 5-year median for Gross Margin is 2.88% (2021), against an average of 7.05%.
- Peak annual rise in Gross Margin reached 10368 bps in 2023, while the deepest fall reached 14221 bps in 2023.
- Cellectis' Gross Margin stood at 27.79% in 2019, then plunged by 32 bps to 36.6% in 2020, then surged by 98 bps to 0.59% in 2021, then soared by 144 bps to 0.26% in 2022, then surged by 39557 bps to 103.94% in 2023.
- Business Quant data shows CLLS's Gross Margin at 103.94% in Q4 2023, 136.77% in Q3 2023, and 69.1% in Q2 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 85.33% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 91.59% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 90.43% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 35.86% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 89.76% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 76.90% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 84.20% |
| 10 | Cellectis | 321.90 Mn | 155.05 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 221.55% |
| Sep 30, 2023 | -136.77% |
| Jun 30, 2023 | 69.10% |
| Mar 31, 2023 | -140.29% |
| Dec 31, 2022 | 0.26% |
| Sep 30, 2022 | -109.71% |
| Jun 30, 2022 | 74.83% |
| Mar 31, 2022 | 1.92% |
| Dec 31, 2021 | -0.59% |
| Sep 30, 2021 | -10.84% |
| Jun 30, 2021 | -5.17% |
| Mar 31, 2021 | -9.15% |
| Dec 31, 2020 | -36.60% |
| Sep 30, 2020 | -26.56% |
| Jun 30, 2020 | -100.93% |
| Mar 31, 2020 | 90.82% |
| Dec 31, 2019 | -27.79% |
| Sep 30, 2019 | 49.85% |
| Jun 30, 2019 | 29.25% |
| Mar 31, 2019 | 43.44% |